This paper is in the following e-collection/theme issue:

#xEpidemiology (8) Infectious Diseases (non-STD/STI) (1719) Hygiene and Infection Prevention (372) Health Services in Resource-Poor Settings and LMICs (533) #xInfectiousDiseases (36)

Published on in Vol 2, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28255, first published .
Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study

Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study

Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study

Authors of this article:

Asaad Mahdi Lehlewa1 Author Orcid Image ;   Hanan Abdulghafoor Khaleel2 Author Orcid Image ;   Faris Lami3 Author Orcid Image ;   Saif Aldeen Falah Hasan2 Author Orcid Image ;   Hasanain Asmail Malick1 Author Orcid Image ;   Razzaq Hashim Mohammed4 Author Orcid Image ;   Qais Abdulazziz Abdulmottaleb5 Author Orcid Image
Article Authors Cited by (8) Tweetations (2) Metrics

Journals

  1. Al-Dubaiee R. Peer Review of “Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study”. JMIRx Med 2021;2(3):e31513 View
  2. Taher R. Peer Review of “Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study”. JMIRx Med 2021;2(3):e31514 View
  3. Nassar A. Peer Review of “Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study”. JMIRx Med 2021;2(3):e31515 View
  4. Lehlewa A, Khaleel H, Lami F, Hasan S, Malick H, Mohammed R, Abdulmottaleb Q. Authors’ Response to Peer Reviews of “Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study”. JMIRx Med 2021;2(3):e31512 View
  5. Knight C, Harris D, Alshammari S, Gugssa A, Young T, Lee C. Leishmaniasis: Recent epidemiological studies in the Middle East. Frontiers in Microbiology 2023;13 View
  6. Muhammed Hassan G, Ali H, Muhammed Hussein W. Evaluation of IL-8, nitric oxide and macrophage inhibitory factor as clinical circulatory markers in patients with cutaneous leishmaniasis, before and during sodium stibogluconate treatment. Cytokine 2024;173:156450 View
  7. Heidari A, Dashtaki N, Mizbani S, Rejali M, Maracy M. Residential environment, human behavior and socio-economic status in transmission of cutaneous leishmaniasis in central Iran. Scientific Reports 2025;15(1) View
  8. Elafef E, Maatoug T, Evangelidou S, Marti-Soler H, Adam A, Arisha A, Hilali M, Hargreaves S, Bani I, Seedat F, Requena-Méndez A. The burden, clinical outcomes and risk factors related to neglected tropical diseases and malaria in migrant populations in the Middle East and North Africa: a systematic review and meta-analyses. BMJ Global Health 2025;10(11):e019713 View